These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 2516906

  • 21. Increased resistance to ciprofloxacin and ofloxacin in multidrug-resistant mycobacterium tuberculosis isolates from patients seen at a tertiary hospital in the Philippines.
    Grimaldo ER, Tupasi TE, Rivera AB, Quelapio MI, Cardaño RC, Derilo JO, Belen VA.
    Int J Tuberc Lung Dis; 2001 Jun; 5(6):546-50. PubMed ID: 11409582
    [Abstract] [Full Text] [Related]

  • 22. Drug resistant tuberculosis in New Zealand.
    Mackay JB.
    N Z Med J; 1978 Sep 13; 88(619):181-3. PubMed ID: 101915
    [Abstract] [Full Text] [Related]

  • 23. [Effect of the inhalation of tuberculostatic aerosols on the dynamics of bacterial excretion in pulmonary tuberculosis patients].
    Protsiuk RG.
    Probl Tuberk; 1983 May 13; (5):38-42. PubMed ID: 6408637
    [No Abstract] [Full Text] [Related]

  • 24. [Clinical analysis of multidrug-resistant tuberculosis].
    Yagi T, Yamagishi F, Sasaki Y, Hamaoka T, Kuroda F, Higurashi H.
    Kekkaku; 2001 Dec 13; 76(12):717-21. PubMed ID: 11806127
    [Abstract] [Full Text] [Related]

  • 25. [Bacilliferous tuberculosis and sensitivity of Koch bacilli to tuberculostatic drugs (current situation in a French hospital service)].
    Oudet P.
    Arch Monaldi; 1972 Dec 13; 27(4):403-17. PubMed ID: 4217597
    [No Abstract] [Full Text] [Related]

  • 26. Drug resistant tuberculosis in Estonia.
    Kruuner A, Sillastu H, Danilovitsh M, Levina K, Svenson SB, Källenius G, Hoffner SE.
    Int J Tuberc Lung Dis; 1998 Feb 13; 2(2):130-3. PubMed ID: 9562123
    [Abstract] [Full Text] [Related]

  • 27. Drug-resistant tuberculosis.
    Iseman MD, Madsen LA.
    Clin Chest Med; 1989 Sep 13; 10(3):341-53. PubMed ID: 2505962
    [Abstract] [Full Text] [Related]

  • 28. Modern short-course regimens in the treatment of tuberculosis.
    Fox W.
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1985 Sep 13; 34(2):122-32. PubMed ID: 2999948
    [No Abstract] [Full Text] [Related]

  • 29. [Approaches to combined therapy of pulmonary tuberculosis in adolescents excreting drug-resistant Mycobacterium tuberculosis].
    Firsova VA, Rusakova LI, Grigor'eva ZP, Ryzhova AP, Iatskova TV, Poluéktova FG.
    Probl Tuberk; 2001 Sep 13; (1):28-30. PubMed ID: 11337776
    [Abstract] [Full Text] [Related]

  • 30. [Clinical significance of Mycobacterium tuberculosis polydrug resistance in chronic destructive forms of pulmonary tuberculosis].
    Bialik IB, Klimenko MT.
    Probl Tuberk; 1980 Oct 13; (10):68-70. PubMed ID: 6776517
    [No Abstract] [Full Text] [Related]

  • 31. [Efficacy of ofloxacin (zanocin) in the treatment of multidrug resistant pulmonary tuberculosis].
    Mishin VIu, Vasil'eva IA.
    Antibiot Khimioter; 2003 Oct 13; 48(8):7-10. PubMed ID: 14722936
    [Abstract] [Full Text] [Related]

  • 32. [Clinical, radiological and bacteriological study of pulmonary tuberculosis with bacteria showing drug resistance].
    Albu A, Hartia V, Esrig E, Galbenu M, Marcovici M, Gălculescu A, Golub M.
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1977 Oct 13; 26(3):151-60. PubMed ID: 201007
    [Abstract] [Full Text] [Related]

  • 33. In vitro drug resistance and response to therapy in pulmonary tuberculosis patients under a DOTS programme in south India.
    Aparna SB, Reddy VC, Gokhale S, Moorthy KV.
    Trans R Soc Trop Med Hyg; 2009 Jun 13; 103(6):564-70. PubMed ID: 19243801
    [Abstract] [Full Text] [Related]

  • 34. [Some epidemiological and clinical aspects of primary resistance to the classic drugs in patients with pulmonary tuberculosis].
    Zierski M.
    Tuberkuloza; 1966 Jun 13; 18(1-3):300-6. PubMed ID: 16296101
    [No Abstract] [Full Text] [Related]

  • 35. [Drug resistance of Mycobacterium tuberculosis in patients with pulmonary tuberculosis treated in the santorium in Abastumani].
    Shilakadze EM, Margadze GKh, Zautashvili MG.
    Probl Tuberk; 1975 Jun 13; (3):79. PubMed ID: 124432
    [No Abstract] [Full Text] [Related]

  • 36. A continuing survey of drug-resistant tuberculosis, New York City, April 1994.
    Fujiwara PI, Cook SV, Rutherford CM, Crawford JT, Glickman SE, Kreiswirth BN, Sachdev PS, Osahan SS, Ebrahimzadeh A, Frieden TR.
    Arch Intern Med; 1997 Mar 10; 157(5):531-6. PubMed ID: 9066457
    [Abstract] [Full Text] [Related]

  • 37. [Factors affecting the efficacy of the treatment of tuberculosis patients discharging drug-resistant mycobacteria].
    Fomicheva NI, Terentieva AS.
    Probl Tuberk; 1981 Dec 10; (12):23-6. PubMed ID: 6801645
    [No Abstract] [Full Text] [Related]

  • 38. [The specific features of bacillary excretion and drug sensitivity in Mycobacterium tuberculosis in patients with recurrent pulmonary tuberculosis].
    Il'iuna TIa, Zhangireev AA, Sidorenko OA.
    Probl Tuberk Bolezn Legk; 2008 Dec 10; (5):20-2. PubMed ID: 18711814
    [Abstract] [Full Text] [Related]

  • 39. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK, Kim JH, Kang H, Cho JS, Smego RA.
    Int J Infect Dis; 2009 Mar 10; 13(2):170-5. PubMed ID: 18768342
    [Abstract] [Full Text] [Related]

  • 40. [Trends in the development of drug resistance in the causative agent of tuberculosis (based on data from an examination of hospital patients)].
    Priĭmak AA, Dolzhanskiĭ VM, Sagalovich VIa, El'murzaeva AA.
    Probl Tuberk; 1985 Mar 10; (8):49-52. PubMed ID: 3932999
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.